EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular Mechanisms of MmpL3 Function and Inhibition

John T Williams, Robert B Abramovitch iD

Microbial Drug Resistance · 01.05.2023 · 29 (5) · 190-212

DOI: 10.1089/mdr.2021.0424 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microbial Drug Resistance, online erschienen am 04.05.2023. Verfasst von John T Williams und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, Michigan, USA. Hauptthemen laut MEDLINE: Membrane Proteins, Mycobacterium tuberculosis. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 213 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacteria species include a large number of pathogenic organisms such as Mycobacterium tuberculosis , Mycobacterium leprae , and various non-tuberculous mycobacteria. Mycobacterial membrane protein large 3 (MmpL3) is an essential mycolic acid and lipid transporter required for growth and cell viability. In the last decade, numerous studies have characterized MmpL3 with respect to protein function, localization, regulation, and substrate/inhibitor interactions. This review summarizes new findings in the field and seeks to assess future areas of research in our rapidly expanding understanding of MmpL3 as a drug target. An atlas of known MmpL3 mutations that provide resistance to inhibitors is presented, which maps amino acid substitutions to specific structural domains of MmpL3. In addition, chemical features of distinct classes of Mmpl3 inhibitors are compared to provide insights into shared and unique features of varied MmpL3 inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane ProteinsMycobacterium tuberculosisBacterial ProteinsMicrobial Sensitivity TestsAnti-Bacterial AgentsAntitubercular Agents

Stichwörter der Autor:innen

MmpL3Mycobacterium tuberculosisphenotypic drug discovery

Substanzen

Membrane ProteinsBacterial ProteinsAnti-Bacterial AgentsAntitubercular Agents

Autor:innen und Institutionen

  • Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, Michigan, USA.

ORCID-Profile: Robert B Abramovitch

Förderung

  • NIAID NIH HHS

Zitieren

APA

Williams, J. T., & Abramovitch, R. B. (2023). Molecular Mechanisms of MmpL3 Function and Inhibition. Microbial Drug Resistance, 29(5), 190-212. https://doi.org/10.1089/mdr.2021.0424

Vancouver

Williams JT, Abramovitch RB. Molecular Mechanisms of MmpL3 Function and Inhibition. Microbial Drug Resistance. 2023;29(5):190-212. doi:10.1089/mdr.2021.0424

BibTeX
@article{Williams2023,
  author = {Williams, John T and Abramovitch, Robert B},
  title = {Molecular Mechanisms of MmpL3 Function and Inhibition},
  journal = {Microbial Drug Resistance},
  year = {2023},
  volume = {29},
  number = {5},
  pages = {190--212},
  doi = {10.1089/mdr.2021.0424}
}
Kostenlos starten →